We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitisWorld Journal of Gastroenterology, May 29, 2015  Full Text  Clinical Article
2Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysisWorld Journal of Gastroenterology, May 29, 2015  Full Text  Clinical Article  Evidence Based Medicine
3The efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infectionAlimentary Pharmacology and Therapeutics, May 29, 2015  Review Article
4Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancerCancer Chemotherapy and Pharmacology, May 29, 2015  Clinical Article
5Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancerCancer Chemotherapy and Pharmacology, May 29, 2015  Clinical Article
6Changing 14-year trends in the epidemiology of hepatitis B virus infection in rural and urban Central–Eastern European areasJournal of Viral Hepatitis, May 29, 2015  Clinical Article
7Prevention of liver cancer through the early detection of risk-related behavior among hepatitis B or C carriersCancer Nursing, May 29, 2015  Clinical Article
8Comparison of liver transplant-related survival benefit in patients with vs without hepatocellular carcinoma in the United StatesGastroenterology, May 29, 2015  Clinical Article
9Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic reviewWorld Journal of Gastroenterology, May 29, 2015  Full Text  Evidence Based Medicine  Review Article
10Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-upGut, May 29, 2015  Clinical Article

Show Me:

We have Ranked, Sorted and Summarized the Latest Clinical Articles.

1FDA approves two therapies to treat IBS-DFDA Press Announcements, May 29, 2015
2Researchers developing new targeted and immune therapies for colorectal cancer molecular subtypesFox Chase Cancer Center News, May 29, 2015
3Diagnosing cancer with help from bacteriaMassachusetts Institute of Technology Research News, May 29, 2015
4Complex signaling between blood and stem cells controls regeneration in fly gutBuck Institute for Research on Aging News, May 28, 2015
5University Hospital of Bellvitge uses a new app for patients with inflammatory bowel diseaseIDIBELL-Bellvitge Biomedical Research Institute News, May 28, 2015
6Research News Tpl2 enzyme may be target for treating autoimmune diseasesUniversity of Georgia Research News, May 27, 2015
7New demonstration project links colorectal cancer screening to discussion and testing for hepatitis CAmerican College of Gastroenterology News, May 27, 2015
8Researchers discover tumor molecule that causes spread of pancreatic cancerFred Hutchinson Cancer Research Center News, May 26, 2015
9In study, skipping meals is linked to abdominal weight gainOhio State University News, May 21, 2015
10Helping doctors predict what's next for patients diagnosed with Hepatitis CUniversity of Michigan Health System, May 21, 2015

Show Me:

Risk factors for intra-abdominal abscesses in Crohn’s disease

As reported in Digestion, uncontrolled CRP at week 14 of therapy with infliximab (OR=1.36) and early loss of response to infliximab (OR=5.36) are independent risk factors for intra-abdominal abscesses in patients with Crohn’s disease.

Risk factors for CHC-related death identified

As reported in the World Journal of Gastroenterology, the following risk factors for chronic hepatitis C (CHC)-related deaths have been identified (n=8250 CHC patients; n=144 CHC-related deaths): α-IFN therapy (AOR=0.53); liver cirrhosis (AOR=2.89); hepatocellular carcinoma versus CHC (AOR=8.82); hypertension (AOR=1.76); alcohol consumption (AOR=1.73); and HBsAg positivity (AOR=22.28).

Calcium reduces CRC risk

As reported in the International Journal of Cancer, there is an 8% reduction in CRC risk with each 300 mg/d increase in calcium intake based on 15 studies involving 12305 patients who took 250-1900 mg of calcium/day over a 3.3-16 year follow-up period. The beneficial effect extended beyond 1000 mg/d.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest Doc99% of patients with hepatitis B virus maintain viral suppression through 7 years.

Clinical Pearl from Smartest DocPatients with a family history of hepatocellular carcinoma require intensive management of HBV infection.

Clinical Pearl from Smartest DocBiological therapy for IBD appears to be compatible with use during conception and during pregnancy.

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here